HIGHLIGHTS
- who: Hai Zhao from the San Martino Hospital (IRCCS), Italy Department of Neurosurgery, the Affiliated Hospital of Qingdao University, Qingdao, China have published the Article: CD47 as a promising therapeutic target in oncology, in the Journal: (JOURNAL)
- what: Inspiring progress has been made with respect to the understanding of the role of CD47 in normal cell growth cycle as well as in the molecular pathogenesis of diverse diseases.
- how: Research data showed that anti-CD47 F(ab') 2 fragment was able to promote engulfment of Raji and other lymphoma cells in_vitro . The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.